Xampla has secured £2 million in seed funding to develop a plant protein-based alternative to microplastics, targeting the growing demand for sustainable solutions in the microencapsulation market.

Target Information

Xampla, a spin-out from the University of Cambridge, is dedicated to combating microplastic pollution. The company has recently secured £2 million in seed funding to advance its innovative technology aimed at providing a plant protein-based alternative for microplastics, which are commonly used in various everyday products.

The startup's primary focus is on the $12 billion microencapsulation market, which currently relies on synthetic polymer capsules. As regulatory bodies such as the EU consider banning synthetic microplastics, Xampla's solution offers a timely and sustainable alternative.

Industry Overview

The microplastics industry has faced increasing scrutiny, particularly in Europe, where the European Chemicals Agency (ECHA) has highlighted the significant environmental impact of added microplastics